Literature DB >> 16115912

Decreased T-cell receptor excision circles in cutaneous T-cell lymphoma.

Kei-ichi Yamanaka1, Nikhil Yawalkar, David A Jones, Daniel Hurwitz, Katalin Ferenczi, Sara Eapen, Thomas S Kupper.   

Abstract

PURPOSE: The T cell repertoire in patients with advanced cutaneous T cell lymphoma (CTCL) is significantly contracted despite the presence of relatively normal absolute numbers of T cells. We propose that many normal T cells were being lost in patients with CTCL, with the remaining normal T cells expanding clonally to fill the T cell compartment. T-cell receptor excision circles (TREC) form as a result of the initial gene rearrangement in naïve T cells. Although they are stable, they do not replicate and are subsequently diluted with the expansion of a population of T cells. Their concentration is therefore a measure of unexpanded naïve T cells relative to T cells that have undergone expansion. EXPERIMENTAL
DESIGN: We analyzed TRECs from unfractionated peripheral blood T cells from 108 CTCL patients by quantitative PCR. In patients with obvious peripheral blood involvement, we also analyzed TRECs from clonal and nonclonal T cells.
RESULTS: We found a decrease in the number of TRECs in peripheral blood of patients with CTCL at all stages of disease, and this decrease was proportional to the loss of complexity of the T cell repertoire as measured by complementarity-determining region 3 spectratyping. In patients with leukemic CTCL and a numerically expanded clone, we also found a significantly lower-than-expected number of TRECs in the nonclonal normal T cells.
CONCLUSIONS: We hypothesize that the nonmalignant T cells have proliferated to fill the empty T cell repertoire space left by the loss of other T cells, leading to diminished TRECs and loss of T-cell receptor diversity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115912     DOI: 10.1158/1078-0432.CCR-04-2514

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  17 in total

1.  Restoration of peripheral blood T cell repertoire complexity during remission in advanced cutaneous T cell lymphoma.

Authors:  Kei-ichi Yamanaka; Robert C Fuhlbrigge; Hitoshi Mizutani; Thomas S Kupper
Journal:  Arch Dermatol Res       Date:  2010-01-29       Impact factor: 3.017

2.  Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma.

Authors:  Kei-ichi Yamanaka; Rachael Clark; Benjamin Rich; Rebecca Dowgiert; Kazuki Hirahara; Daniel Hurwitz; Michio Shibata; Nina Mirchandani; David A Jones; Deborah S Goddard; Sara Eapen; Hitoshi Mizutani; Thomas S Kupper
Journal:  Blood       Date:  2005-12-01       Impact factor: 22.113

3.  Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease.

Authors:  Joshua D Milner; Jerrold M Ward; Andrea Keane-Myers; William E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

4.  Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma.

Authors:  Maria Wysocka; Noor Dawany; Bernice Benoit; Andrew V Kossenkov; Andrea B Troxel; Joel M Gelfand; Michael Kelly Sell; Louise C Showe; Alain H Rook
Journal:  Leuk Lymphoma       Date:  2011-10

5.  Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma.

Authors:  Filiberto Cedeno-Laurent; Rei Watanabe; Jessica E Teague; Thomas S Kupper; Rachael A Clark; Charles J Dimitroff
Journal:  Blood       Date:  2012-03-01       Impact factor: 22.113

Review 6.  Mycosis fungoides and sezary syndrome: an update.

Authors:  Ellen J Kim; Julie Lin; Jacqueline M Junkins-Hopkins; Carmela C Vittorio; Alain H Rook
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

Review 7.  Infectious agents in cutaneous T-cell lymphoma.

Authors:  Ezra D Mirvish; Rebecca G Pomerantz; Larisa J Geskin
Journal:  J Am Acad Dermatol       Date:  2010-08-07       Impact factor: 11.527

8.  Regulation gone wrong: a subset of Sézary patients have malignant regulatory T cells.

Authors:  Rachael A Clark
Journal:  J Invest Dermatol       Date:  2009-12       Impact factor: 8.551

9.  Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma.

Authors:  Katja C Weisel; Eckhart Weidmann; Ioannis Anagnostopoulos; Lothar Kanz; Antonio Pezzutto; Marion Subklewe
Journal:  Int J Hematol       Date:  2008-10-07       Impact factor: 2.490

10.  Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome.

Authors:  Jessica Shin; Stefano Monti; Daniel J Aires; Madeleine Duvic; Todd Golub; David A Jones; Thomas S Kupper
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.